Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
If approved, Wegovy would become the first oral formulation of a GLP-1 indicated for chronic weight management
People were writing us asking, Do you have anything that increases GLP-1 levels? Do you have anything around weight management? Do you have anything around appetite regulation? So we started developing this product two years ago. Before it launched GLP-1 Daily, Lemme put out Lemme Curb, aimed at reducing sugar and carb cravings, and Lemme Burn, intended to increase the users metabolism and combat belly fat
**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide/tirzepatide for weight loss and related outcomes within the WW Clinic Program who increased their Healthy Eating Index score from 55.0 to 65.1
Efficacy comparison by clinical trial data The most relevant head-to-head data comes from the SURPASS-2 trial (tirzepatide vs semaglutide 1 mg for type 2 diabetes) and the SURMOUNT-5 trial (tirzepatide vs semaglutide 2.4 mg for obesity)
Drugs impacting autonomic nervous system function, including many GLP-1 receptor agonists, can suppress salivary gland activity
Both Diamond Cherry and Crystal Tomato supplements are designed to lighten melasma and pigmentation while protecting the skin from environmental damage such as free radicals and UV radiation
